Closing Bell: Nervgen Pharma Corp down on Monday (NGEN)

In today's trading, Nervgen Pharma Corp stock opened at $2.34 and closed at $2.30. prices ranged from a low of $2.28 to a high of $2.35.

The price eased -0.86% from the previous day's close of $2.32.

During the day across North America, the TSX Composite closed -0.24% at 21587.88, the S&P 500 closed -0.04% at 5431.60, the Dow Jones Industrial Average closed -0.15% at 38589.16 and the Nasdaq Composite closed 0.12% at 17688.88.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

A total of 14,741 shares was traded during the session, with total trades of 54. On average, Nervgen Pharma Corp has traded 143,748 shares in the last five days and 91,031 year-to-date.

Trading across the entire TSX-V saw 2,775 price advancers against 2,492 declines and 97 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, the shares have boosted 37.72% in 52 weeks, while they have dipped -14.81% since the start of 2024.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $162.23 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Nervgen Pharma Corp is holding an average recommendation of "Strong Sell" from 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..